MULTIMERIC PROTEINS OF THE PEROXIREDOXIN FAMILY AS SCAFFOLD PROTEINS

PEROXIREDOXIN 6 OR A SYNTHETIC ANALOGUE THEREOF FOR USE AS A HYPOGLYCAEMIC AGENT

SYNTHETIC GENES

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

SYNTHETIC GENES

Reduction of lipase activity in product formulations

Causative genes conferring acetic acid tolerance in yeast

MULTIPROTEIN ASSEMBLIES

Reduction of lipase activity in product formulations

Application of PRDX2 and/or PRDX6 in improving sperm quality or treating male infertility

Method for controlling the chaperone activity of peroxiredoxins using irradiation

Synthetic genes

Methods and compositions using peroxiredoxin 1 (PRX1) as an adjuvant

Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1)

PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RESTENOSIS COMPRISING PEROXIREDOXIN 2 PROTEIN AS AN ACTIVE INGREDIENT AND COMPOSITION FOR SCREENING THERAPEUTICS OF RESTENOSIS COMPRISING PEROXIREDOXIN 2 GENE OR ITS PROTEIN PRODUCT, AND METHOD FOR SCREENING TH

PEROXIREDOXIN DRUGS FOR TREATMENT OF HIV-1 INFECTION AND METHODS OF USE THEREOF

Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening therapeutics of restinosis using said composition

Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure

Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof